FDA Person
FDAXiaoshi Wang
View detailed information about Xiaoshi Wang, including compliance records, violations, and related data.
Person Profile
FDA investigator. Took part in 3 inspections of 3 companies, 2024–2026.
Inspections (3)
| Date | Company | Classification | Project area | Inspection |
|---|---|---|---|---|
| May 20, 2026 | Shanghai Henlius Biopharmaceuticals Co., Ltd. | Not classified | #1320008 | |
| September 19, 2025 | Amphastar Nanjing Pharmaceuticals Inc | Not classified | #1291882 | |
| July 26, 2024 | Biocon Biologics Limited | VAI | Drug Quality Assurance | #1245708 |
Documents (8)
- EIR · GlaxoSmithKline dba Human Genome Sciences Inc · January 29, 2020
- 483 · Amphastar Nanjing Pharmaceuticals Inc · September 19, 2025
- EIR · Merck Sharp & Dohme LLC · September 20, 2019
- 483 · Biocon Biologics Limited
- 483 · Patheon Biologics LLC · November 10, 2023
- 483 · GlaxoSmithKline dba Human Genome Sciences Inc
- 483 · Biocon Biologics Limited · July 26, 2024
- 483 · Shanghai Henlius Biopharmaceuticals Co., Ltd. · May 20, 2026
Person Information
Name
Xiaoshi Wang
ID: 8249ff14-dec6-4ffd-9893-bdf8ba6af7ce
Get More Insights
Access our comprehensive quality intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
1.5M+ regulatory data points
Real-time compliance monitoring
Interactive analytics dashboard
Looking for more people? Our platform provides access to thousands of FDA people with advanced search and filtering capabilities.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.